September 29th at 2:00pm ET
“Strategies to advance your biologic products to the clinic with a path to commercial launch”
Walk away with a better understanding of:
- Investment in disruptive technologies to advance the manufacturing paradigm
- Structured approach to development, transfer, validation, and commercialization
- Optimization of clinical programs for robust and reliable commercial supply of bulk drug substance and drug product
- Merging technical depth with next-gen digital and regulatory capabilities for commercial supply
